| Entry |
|
|---|
| Name |
|
|---|
| Formula |
C8H16O2
|
|---|
| Exact mass |
144.115
|
|---|
| Mol weight |
144.2114
|
|---|
| Structure |
   |
|---|
| Remark |
|
|---|
| Reaction |
|
|---|
| Pathway |
| map00982 | Drug metabolism - cytochrome P450 |
|
|---|
| Enzyme |
1.14.13.- 1.14.14.-
|
|---|
| Brite |
Target-based classification of compounds [BR:br08010]
Enzymes
Transferases
4-aminobutyrate aminotransferase
C07185 Valproic acid
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N03 ANTIEPILEPTICS
N03A ANTIEPILEPTICS
N03AG Fatty acid derivatives
N03AG01 Valproic acid
D00399 Valproic acid (USP) <US>
USP drug classification [BR:br08302]
Anticonvulsants
Anticonvulsants, Other
Valproic Acid
D00399 Valproic acid (USP)
Antimigraine Agents
Prophylactic
Valproic Acid
D00399 Valproic acid (USP)
Bipolar Agents
Mood Stabilizers
Valproic Acid
D00399 Valproic acid (USP)
Target-based classification of drugs [BR:br08310]
Ion channels
Voltage-gated ion channels
Calcium channels
CACNA1-T
D00399 Valproic acid (USP) <US>
Enzymes
Oxidoreductases (EC1)
Dehydrogenases
SSADH
D00399 Valproic acid (USP) <US>
Transferases (EC2)
Aminotransferase
ABAT
D00399 Valproic acid (USP) <US>
Lyases (EC4)
Carboxy-lyases
GAD
D00399 Valproic acid (USP) <US>
Pharmacogenomic biomarkers [br08341.html]
Polymorphisms and mutations affecting drug response
D00399
 |
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 10
1 C1c C 25.4573 -18.6784
2 C1b C 25.4573 -17.3002
3 C1b C 24.2485 -19.3967
4 C6a C 26.6604 -19.3967
5 C1b C 24.2427 -16.5935
6 C1b C 23.0396 -18.6784
7 O6a O 26.6604 -20.7925
8 O6a O 27.8692 -18.6784
9 C1a C 23.0339 -17.3002
10 C1a C 21.8367 -19.3967
BOND 9
1 1 2 1
2 1 3 1
3 1 4 1
4 2 5 1
5 3 6 1
6 4 7 1
7 4 8 2
8 5 9 1
9 6 10 1
|
|---|
